See every side of every news story
Published loading...Updated

Curium Pharma announces acquisition of Monrol - Pharmafile

Summary by pharmafile.com
Curium Pharma, a nuclear medicine company, has acquired Eczacıbaşı-Monrol Nuclear Products (Monrol), a nuclear medicine player. With facilities across Europe and the US, Curium develops, manufactures and distributes radiopharmaceutical products to help patients with life-threatening diseases. It is a contract development and manufacturing organisation (CDMO) and offers single photon emission computed tomography (SPECT), positron emission […] The…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

pharmafile.com broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.